Neural tube defects in austria: Assumption and calculations on the prevention potential through folic acid enrichment and supplementation;Neuralrohrdefekte in Österreich: Annahmen und Berechnungen zum Verhinderungspotenzial durch Folsäureanreicherung und-supplemente

Gesundheitswesen

Volumn 72, Issue 12, 2010, Pages 880-885

  Schiller Fruhwirth I ^a   Mittermayr, T ^a   Wild, C ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

folic acid; food supplementation; fortification; neural tube defects

Indexed keywords

FOLIC ACID; VITAMIN B COMPLEX;

ARTICLE; AUSTRIA; DIET SUPPLEMENTATION; FEMALE; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; MALE; NEURAL TUBE DEFECT; ORGANIZATION AND MANAGEMENT; PREGNANCY; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR;

AUSTRIA; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HEALTH POLICY; HUMANS; MALE; NEURAL TUBE DEFECTS; PREGNANCY; PREVALENCE; PROPORTIONAL HAZARDS MODELS; REGIONAL MEDICAL PROGRAMS; RISK ASSESSMENT; RISK FACTORS; VITAMIN B COMPLEX;

EID: 78650135623     PISSN: 09413790     EISSN: 14394421     Source Type: Journal    
DOI: 10.1055/s-0029-1246172     Document Type: Article

References (25)

1. Schiller-Frühwirth I, Johanson T, Göbl M, et al. Risiko und Nutzen von Folsäure-Anreicherung im Mehl in Österreich. LBI-HTA Projektbericht 2008 20
2. Elwood JM, Little J, Elwood JH. Epidemiology and control of neural tube defects. Oxford; New York Oxford University Press 1992
3. Romijn JA, Treffers PE. Anencephaly in the Netherlands: a remarkable decline. Lancet 1983 Jan 1 1 (8314-5) 64-65
4. Kadir RA, Sabin C, Whitlow B, et al. Neural tube defects and periconceptional folic acid in England and Wales: retrospective study. BMJ. 1999 Jul 10 319 (7202) 92-93
5. EUROCAT working group. EUROCAT Report 4: Surveillance of congenital anomalies 19801988. EUROCAT central registry department of epidemiology. Catholic University of Louvain, Brüssel 1991
6. Field B. Neural tube defects in New South Wales, Australia. J Med Genet. 1978 Oct 15 (5) 329-338
7. Hemminki K, Mutanen P, Saloniemi I, et al. Congenital malformations and maternal occupation in Finland: multivariate analysis. J Epidemiol Community Health 1981Mar 35 (1) 5-10
8. Elwood JH, Nevin NC. Factors associated with anencephalus and spina bifida in Belfast. Br J Prev Soc Med 1973 May 27 (2) 73-80
9. Naggan L, MacMahon B. Ethnic differences in the prevalence of anencephaly and sina bifida in Boston, Massachusetts. N Engl J Med 1967 Nov 23 277 (21) 1119-1123
10. Vrijheid M, Dolk H, Stone D, et al. Socioeconomic inequalities in risk of congenital anomaly. Arch Dis Child 2000May 82 (5) 349-352
11. Buselmaier W, Tariverdian G. Humangenetik: mit 144 Übersichten. 2., völlig neu bearb. Aufl ed. Berlin [u. a.] Springer 1999
12. EUROCAT/ European Surveillance of Congenital Anomalies. [zitiert 2008. 20.10] eurocat.ulster.ac.uk/pdf/reg-des/styria.pdf
13. Murken J. Humangenetik: 56 Tabellen. 6., durchges. Aufl 1. [Dr.]. ed Stuttgart: Enke 1996
14. STATISTIK AUSTRIA. Jahrbuch der Gesundheitsstatistik 2004. 2005 [zitiert 2008. 20.10] www.statistik.at/dynamic/wcmsprod/ idcplg?idcservice=get-native- file&did=37079&ddocname=008879
15. STATISTIK AUSTRIA. Jahrbuch der Gesundheitsstatistik 2005. 2006 [zitiert 2008. 20.10] www.statistik.at/dynamic/wcmsprod/ idcplg?idcservice=get-native- file&did=39974&ddocname=018797
16. STATISTIK AUSTRIA. Jahrbuch der Gesundheitsstatistik 2006. 2007 [zitiert 2008. 20.10] www.statistik.at/dynamic/wcmsprod/ idcplg?idcservice=get-native- file&did=57559&ddocname=028435
17. EUROCAT. European Surveillance of Congenital Anomalies (EUROCAT) Special Report Prevention of Neural Tube Defects by Periconceptional Folic Acid Supplementation in Europe. 2003 [zitiert 2008.10.20] ec.europa.eu/health/ph- projects/2001/rare-diseases/fp-raredis-2001-a4-01-en.pdf
18. Bundesministerium für Gesundheit Familie und Jugend/BMGFJ LKF Modell 2009. [zitiert 2008. 20.10.] www.bmgfj.gv.at/cms/site/ standard.html?channel= ch0719&doc=cms1159517118526
19. Pollak A, Gruber W, Birnbacher R, et al. Richtlinien zur Prävention von Neuralrohredefekten durch perikonzeptionelle Folsäuresubstitution. Perinatal Medizin 1998 10 73-74
20. Zwiauer K, Groll D, Weissensteiner M. Folsäuresubstitution bei Schwangeren: Ergebnisse einer regionalen Untersuchung im Raum St. Pölten. Pädiatrie/Pädologie 2000 Vol 6 14-17
21. Stengl S, Schmidt A, Salzer H. Folsäure zum Schutz vor Neuralrohrschlussstörungen. Informationsstand von Patientinnen und Ärzten Geburtshilfe und Frauenheilkunde. 2000 60 26-29
22. Daly S, Mills JL, Molloy AM, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 1997Dec6 350 (9092) 1666-1669
23. Wald NJ, Law MR, Morris JK, et al. Quantifying the effect of folic acid. Lancet 2001 Dec 15 358 (9298) 2069-2073
24. Lumley J, Watson L, Watson M, et al. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev 2001 (3) CD001056
25. Rader J, Weaver C, Angyal G. Advances in the analysis of folates in foods. Food Test Anal. 1999 5 14-32